Estrogen receptor-alpha phosphorylation at serine-118 and tamoxifen response in breast cancer

Journal of the National Cancer Institute
Marleen KokGöran Landberg

Abstract

Although estrogen receptor-alpha (ER) [corrected] is a marker used to identify breast cancer patients most likely to benefit from endocrine therapy, approximately 50% of ER-positive [corrected] breast carcinomas are resistant to tamoxifen. Preclinical studies have shown that phosphorylation of ER [corrected] at serine-118 (ER alpha S118-P) is required for tamoxifen-mediated inhibition of ER-induced [corrected] gene expression. We evaluated the association between recurrence-free survival after tamoxifen treatment and ER alpha S118-P expression by use of Cox proportional hazards regression. Data were from 239 premenopausal patients with breast cancer who participated in a randomized trial of 2 years of adjuvant tamoxifen treatment vs no systemic treatment. ER alpha S118-P expression was assessed by immunohistochemistry and categorized by use of the Allred score (low expression = score of 0-6; high expression = score of 7-8). All statistical tests were two-sided. Compared with systemically untreated patients, we found evidence of a benefit from adjuvant tamoxifen among patients whose tumors had high ER alpha S118-P expression (23.7 recurrences per 1000 person-years versus 72.2 recurrences per 1000 person-years, hazard ratio [HR] ...Continue Reading

References

Mar 15, 2003·Nature Reviews. Cancer·Simak Ali, R Charles Coombes
Feb 24, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Leigh MurphyPeter Watson
Sep 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Leigh C MurphyPeter Watson
Jan 22, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Lisa RydénUNKNOWN South-East Swedish Breast Cancer Group
Mar 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel J SargentLaurence Collette
Aug 18, 2005·Journal of the National Cancer Institute·Lisa M McShaneUNKNOWN Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics
Apr 11, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jenny BergqvistJonas Bergh
May 18, 2006·Journal of the National Cancer Institute·Caroline HolmGöran Landberg
Oct 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jie JiangSimak Ali
Jan 4, 2008·Histopathology·S J L PayneC A Wells
Apr 26, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ZoubirF Andre
Dec 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniele GeneraliStephen B Fox

❮ Previous
Next ❯

Citations

Apr 3, 2013·European Journal of Pharmacology·Marjolein DroogWilbert Zwart
Jul 23, 2011·Nature Reviews. Cancer·Christoforos Thomas, Jan-Åke Gustafsson
Jul 25, 2012·Nature Reviews. Clinical Oncology·Karin BeelenSabine C Linn
Sep 10, 2010·Current Opinion in Oncology·Giuseppe VialeMauro G Mastropasqua
Sep 3, 2011·Circulation Research·Elizabeth Murphy
Feb 2, 2012·International Journal of Breast Cancer·Renée de LeeuwRob Michalides
May 2, 2014·Molecular Cancer·Zsuzsanna NagyGabriella Czifra
Apr 11, 2015·Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada·Tijana VujasinovicMarko Radulovic
Feb 26, 2016·The Journal of Endocrinology·Koen D Flach, Wilbert Zwart
Aug 11, 2010·The American Journal of Pathology·Werbena Hamilton-BurkeValerie Speirs
Mar 28, 2017·Cellular Signalling·Angeles C Tecalco-CruzLeticia Rocha-Zavaleta
Jul 28, 2018·Molecular Oncology·Samira BenhadjebaAndré Tremblay
Jun 18, 2011·Endocrine Reviews·Muriel Le RomancerLaura Corbo
Sep 7, 2019·International Journal of Cancer. Journal International Du Cancer·Dinja T KrugerSabine C Linn
Apr 3, 2020·Cell Stress & Chaperones·Rebecca A SagerMehdi Mollapour
Feb 10, 2011·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Wilbert ZwartJason S Carroll
Jan 18, 2017·Molecular Cancer Research : MCR·Ali Vaziri-GoharKevin D Houston
Aug 16, 2018·Acta Pharmaceutica Sinica. B·Xiao-Mei QiGuan Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.